EIR Zhejiang Kangle Pharmaceutical Jun 2001

Robert Horan FDA, Susan Ting FDA$595.00 - Available Now

FDA investigators audited the Zhejiang Kangle Pharmaceutical - Wenzhou, Zhejiang, China facility and issued inspectional observation (via FDA 483) on 02 Jun 2001.

Product details

  • Category:
  • Inspection end: 02 Jun 2001
  • Location: Wenzhou, Zhejiang, China
  • FEI: 3003311250
Add To Cart